Myelodysplastic Syndrome
17 drugs4,546 FAERS reportsMedDRA PT
GET
/api/v1/reaction/myelodysplastic-syndromeReference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.
Drugs reporting Myelodysplastic Syndrome (17)
Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.
- 1Azurite111%
- 2Cornsilk111%
- 3Ibritumomab Tiuxetan986.4%
- 4Carmustine2906.4%
- 5Pentetreotide64.7%
- 6Indium64.1%
- 7Mitoxantrone2373.8%
- 8Melphalan6982.8%
- 9Axicabtagene Ciloleucel2612.8%
- 10Luspatercept622.7%
- 11Ifosfamide5542.7%
- 12Azacitidine7632.7%
- 13Chlorambucil1002.6%
- 14Idarubicin262.4%
- 15Fludarabine9172.4%
- 16Olaparib4722.3%
- 17Brexucabtagene Autoleucel54—
Related reactions
Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.
- Acute Myeloid Leukaemia9 shared · 0.26
- Squamous Cell Carcinoma Of Skin3 shared · 0.15
- Bone Marrow Failure4 shared · 0.13
- Benign Neoplasm Of Thyroid Gland2 shared · 0.12
- Blood Bilirubin Abnormal2 shared · 0.12
- Gambling2 shared · 0.12
- Metastasis2 shared · 0.12
- Platelet Disorder2 shared · 0.12
- Platelet Toxicity2 shared · 0.12
- White Blood Cell Disorder2 shared · 0.12
Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.